Dobson CM (2001). “The structural basis of protein folding and its links with human disease”. Philos. Trans. R. Soc. Lond. B Biol. Sci.356 (1406): 133–145. doi:10.1098/rstb.2000.0758. PMID11260793.
Lindquist S, Krobitsch S, Li L and Sondheimer N (2001). “Investigating protein conformation-based inheritance and disease in yeast”. Philos. Trans. R. Soc. Lond. B Biol. Sci.356 (1406): 169–176. doi:10.1098/rstb.2000.0762. PMID11260797.
Alper T, Cramp W, Haig D, Clarke M (1967). “Does the agent of scrapie replicate without nucleic acid?”. Nature214 (5090): 764–6. doi:10.1038/214764a0. PMID4963878.
Hegde RS, Mastrianni JA, Scott MR, Defea KA, Tremblay P, Torchia M, DeArmond SJ, Prusiner SB, Lingappa VR (1998). “A transmembrane form of the prion protein in neurodegenerative disease”. Science276: 827–834. doi:10.1126/science.279.5352.827. PMID9452375.
Gilch, Sabine, et al. (2001). “Intracellular re-routing of prion protein prevents propagation of PrPSc and delays onset of prion disease”. The EMBO Journal20 (15): 3957–3966. doi:10.1093/emboj/20.15.3957. PMID11483499.
Büeler H, Aguzzi A, Sailer A, Greiner R, Autenried P, Aguet M, Weissmann C (1993). “Mice devoid of PrP are resistant to scrapie”. Cell73 (7): 1339–47. doi:10.1016/0092-8674(93)90360-3. PMID8100741.
Ironside, JW (2006). “Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies”. Haemophilia12 (s1): 8–15. doi:10.1111/j.1365-2516.2006.01195.x. PMID16445812.
Telling G, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen F, DeArmond S, Prusiner S (1995). “Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein”. Cell83 (1): e93. doi:10.1016/0092-8674(95)90236-8. PMID7553876.
Johnson C, Pedersen, Chappell R, McKenzie D, Aiken J (2007). “Oral Transmissibility of Prion Disease is Enhanced by Binding to Soil Particles”. PLoS Pathogens3 (7): e93. doi:10.1371/journal.ppat.0030093. PMID17616973.
Weissmann C, Enari M, Klöhn PC, Rossi D, Flechsig E (2002). “Transmission of prions”. Proc. Natl. Acad. Sci. U.S.A.99 Suppl 4: 16378–83. doi:10.1073/pnas.172403799. PMID12181490.
Sutton JM, Dickinson J, Walker JT and Raven NDH (2006). “Methods to Minimize the Risks of Creutzfeldt-Jakob Disease by Surgical Procedures: Where to Set the Standard?”. Clinical Infectious Diseases43: 757–64. doi:10.1086/507030. PMID16912952.
Geoghegan JC, Valdes PA, Orem NR, et al (December 2007). “Selective incorporation of polyanionic molecules into hamster prions”. J. Biol. Chem.282 (50): 36341–53. doi:10.1074/jbc.M704447200. PMID17940287.
Manuelidis L (March 2007). “A 25 nm virion is the likely cause of transmissible spongiform encephalopathies”. J. Cell. Biochem.100 (4): 897–915. doi:10.1002/jcb.21090. PMID17044041.
Halfmann R, Alberti S, Lindquist S (2010). “Prions, protein homeostasis, and phenotypic diversity”. Trends in Cell Biology. doi:10.1016/j.tcb.2009.12.003. PMID20071174.
Dobson CM (2001). “The structural basis of protein folding and its links with human disease”. Philos. Trans. R. Soc. Lond. B Biol. Sci.356 (1406): 133–145. doi:10.1098/rstb.2000.0758. PMID11260793.
Lindquist S, Krobitsch S, Li L and Sondheimer N (2001). “Investigating protein conformation-based inheritance and disease in yeast”. Philos. Trans. R. Soc. Lond. B Biol. Sci.356 (1406): 169–176. doi:10.1098/rstb.2000.0762. PMID11260797.
Alper T, Cramp W, Haig D, Clarke M (1967). “Does the agent of scrapie replicate without nucleic acid?”. Nature214 (5090): 764–6. doi:10.1038/214764a0. PMID4963878.
Hegde RS, Mastrianni JA, Scott MR, Defea KA, Tremblay P, Torchia M, DeArmond SJ, Prusiner SB, Lingappa VR (1998). “A transmembrane form of the prion protein in neurodegenerative disease”. Science276: 827–834. doi:10.1126/science.279.5352.827. PMID9452375.
Brown DR (1997). “The cellular prion protein binds copper in vivo.”. Nature390: 684–687. PMID9414160.
Gilch, Sabine, et al. (2001). “Intracellular re-routing of prion protein prevents propagation of PrPSc and delays onset of prion disease”. The EMBO Journal20 (15): 3957–3966. doi:10.1093/emboj/20.15.3957. PMID11483499.
Büeler H, Aguzzi A, Sailer A, Greiner R, Autenried P, Aguet M, Weissmann C (1993). “Mice devoid of PrP are resistant to scrapie”. Cell73 (7): 1339–47. doi:10.1016/0092-8674(93)90360-3. PMID8100741.
Ironside, JW (2006). “Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies”. Haemophilia12 (s1): 8–15. doi:10.1111/j.1365-2516.2006.01195.x. PMID16445812.
Telling G, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen F, DeArmond S, Prusiner S (1995). “Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein”. Cell83 (1): e93. doi:10.1016/0092-8674(95)90236-8. PMID7553876.
Johnson C, Pedersen, Chappell R, McKenzie D, Aiken J (2007). “Oral Transmissibility of Prion Disease is Enhanced by Binding to Soil Particles”. PLoS Pathogens3 (7): e93. doi:10.1371/journal.ppat.0030093. PMID17616973.
Weissmann C, Enari M, Klöhn PC, Rossi D, Flechsig E (2002). “Transmission of prions”. Proc. Natl. Acad. Sci. U.S.A.99 Suppl 4: 16378–83. doi:10.1073/pnas.172403799. PMID12181490.
Sutton JM, Dickinson J, Walker JT and Raven NDH (2006). “Methods to Minimize the Risks of Creutzfeldt-Jakob Disease by Surgical Procedures: Where to Set the Standard?”. Clinical Infectious Diseases43: 757–64. doi:10.1086/507030. PMID16912952.
Geoghegan JC, Valdes PA, Orem NR, et al (December 2007). “Selective incorporation of polyanionic molecules into hamster prions”. J. Biol. Chem.282 (50): 36341–53. doi:10.1074/jbc.M704447200. PMID17940287.
Manuelidis L (March 2007). “A 25 nm virion is the likely cause of transmissible spongiform encephalopathies”. J. Cell. Biochem.100 (4): 897–915. doi:10.1002/jcb.21090. PMID17044041.
Halfmann R, Alberti S, Lindquist S (2010). “Prions, protein homeostasis, and phenotypic diversity”. Trends in Cell Biology. doi:10.1016/j.tcb.2009.12.003. PMID20071174.